Central adiponectin acutely improves glucose tolerance in male mice

Christiane E Koch, Chrishanthi Lowe, Karen Legler, Jonas Benzler, Alisa Boucsein, Gregor Böttiger, David R Grattan, Lynda M Williams, Alexander Tups

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Adiponectin, an adipocyte-derived hormone, regulates glucose and lipid metabolism. It is also antiinflammatory. During obesity, adiponectin levels and sensitivity are reduced. Whereas the action of adiponectin in the periphery is well established the neuroendocrine role of adiponectin is largely unknown. To address this we analyzed the expression of adiponectin and the 2 adiponectin receptors (AdipoR1 and AdipoR2) in response to fasting and to diet-induced and genetic obesity. We also investigated the acute impact of adiponectin on central regulation of glucose homeostasis. Adiponectin (1 μg) was injected intracerebroventricularly (ICV), and glucose tolerance tests were performed in dietary and genetic obese mice. Finally, the influence of ICV adiponectin administration on central signaling cascades regulating glucose homeostasis and on markers of hypothalamic inflammation was assessed. Gene expression of adiponectin was down-regulated whereas AdipoR1 was up-regulated in the arcuate nucleus of fasted mice. High-fat (HF) feeding increased AdipoR1 and AdipoR2 gene expression in this region. In mice on a HF diet and in leptin-deficient mice acute ICV adiponectin improved glucose tolerance 60 minutes after injection, whereas normoglycemia in control mice was unaffected. ICV adiponectin increased pAKT, decreased phospho-AMP-activated protein kinase, and did not change phospho-signal transducer and activator of transcription 3 immunoreactivity. In HF-fed mice, ICV adiponectin reversed parameters of hypothalamic inflammation and insulin resistance as determined by the number of phospho-glycogen synthase kinase 3 β(Ser9) and phospho-c-Jun N-terminal kinase (Thr183/Tyr185) immunoreactive cells in the arcuate nucleus and ventromedial hypothalamus. This study demonstrates that the insulin-sensitizing properties of adiponectin are at least partially based on a neuroendocrine mechanism that involves centrally synthesized adiponectin.

Original languageEnglish
Pages (from-to)1806-1816
Number of pages11
JournalEndocrinology
Volume155
Issue number5
Early online date24 Feb 2014
DOIs
Publication statusPublished - 2014

Fingerprint

Adiponectin
Glucose
Arcuate Nucleus of Hypothalamus
Homeostasis
Obesity
Adiponectin Receptors
Fats
Inflammation
Glycogen Synthase Kinase 3
Gene Expression
STAT3 Transcription Factor
Obese Mice
AMP-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases
High Fat Diet
Glucose Tolerance Test
Leptin
Lipid Metabolism
Adipocytes
Insulin Resistance

Keywords

  • Adiponectin
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal
  • Arcuate Nucleus
  • Diet, High-Fat
  • Glucose Intolerance
  • Hypoglycemic Agents
  • Injections, Intraventricular
  • Insulin Resistance
  • Leptin
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Nerve Tissue Proteins
  • Neurons
  • Obesity
  • Receptors, Adiponectin
  • Signal Transduction
  • Ventromedial Hypothalamic Nucleus

Cite this

Koch, C. E., Lowe, C., Legler, K., Benzler, J., Boucsein, A., Böttiger, G., ... Tups, A. (2014). Central adiponectin acutely improves glucose tolerance in male mice. Endocrinology, 155(5), 1806-1816. https://doi.org/10.1210/en.2013-1734

Central adiponectin acutely improves glucose tolerance in male mice. / Koch, Christiane E; Lowe, Chrishanthi; Legler, Karen; Benzler, Jonas; Boucsein, Alisa; Böttiger, Gregor; Grattan, David R; Williams, Lynda M; Tups, Alexander.

In: Endocrinology, Vol. 155, No. 5, 2014, p. 1806-1816.

Research output: Contribution to journalArticle

Koch, CE, Lowe, C, Legler, K, Benzler, J, Boucsein, A, Böttiger, G, Grattan, DR, Williams, LM & Tups, A 2014, 'Central adiponectin acutely improves glucose tolerance in male mice', Endocrinology, vol. 155, no. 5, pp. 1806-1816. https://doi.org/10.1210/en.2013-1734
Koch CE, Lowe C, Legler K, Benzler J, Boucsein A, Böttiger G et al. Central adiponectin acutely improves glucose tolerance in male mice. Endocrinology. 2014;155(5):1806-1816. https://doi.org/10.1210/en.2013-1734
Koch, Christiane E ; Lowe, Chrishanthi ; Legler, Karen ; Benzler, Jonas ; Boucsein, Alisa ; Böttiger, Gregor ; Grattan, David R ; Williams, Lynda M ; Tups, Alexander. / Central adiponectin acutely improves glucose tolerance in male mice. In: Endocrinology. 2014 ; Vol. 155, No. 5. pp. 1806-1816.
@article{428f897212f043cdbbf0593ef4e51828,
title = "Central adiponectin acutely improves glucose tolerance in male mice",
abstract = "Adiponectin, an adipocyte-derived hormone, regulates glucose and lipid metabolism. It is also antiinflammatory. During obesity, adiponectin levels and sensitivity are reduced. Whereas the action of adiponectin in the periphery is well established the neuroendocrine role of adiponectin is largely unknown. To address this we analyzed the expression of adiponectin and the 2 adiponectin receptors (AdipoR1 and AdipoR2) in response to fasting and to diet-induced and genetic obesity. We also investigated the acute impact of adiponectin on central regulation of glucose homeostasis. Adiponectin (1 μg) was injected intracerebroventricularly (ICV), and glucose tolerance tests were performed in dietary and genetic obese mice. Finally, the influence of ICV adiponectin administration on central signaling cascades regulating glucose homeostasis and on markers of hypothalamic inflammation was assessed. Gene expression of adiponectin was down-regulated whereas AdipoR1 was up-regulated in the arcuate nucleus of fasted mice. High-fat (HF) feeding increased AdipoR1 and AdipoR2 gene expression in this region. In mice on a HF diet and in leptin-deficient mice acute ICV adiponectin improved glucose tolerance 60 minutes after injection, whereas normoglycemia in control mice was unaffected. ICV adiponectin increased pAKT, decreased phospho-AMP-activated protein kinase, and did not change phospho-signal transducer and activator of transcription 3 immunoreactivity. In HF-fed mice, ICV adiponectin reversed parameters of hypothalamic inflammation and insulin resistance as determined by the number of phospho-glycogen synthase kinase 3 β(Ser9) and phospho-c-Jun N-terminal kinase (Thr183/Tyr185) immunoreactive cells in the arcuate nucleus and ventromedial hypothalamus. This study demonstrates that the insulin-sensitizing properties of adiponectin are at least partially based on a neuroendocrine mechanism that involves centrally synthesized adiponectin.",
keywords = "Adiponectin, Animals, Anti-Inflammatory Agents, Non-Steroidal, Arcuate Nucleus, Diet, High-Fat, Glucose Intolerance, Hypoglycemic Agents, Injections, Intraventricular, Insulin Resistance, Leptin, Male, Mice, Mice, Inbred C57BL, Mice, Obese, Nerve Tissue Proteins, Neurons, Obesity, Receptors, Adiponectin, Signal Transduction, Ventromedial Hypothalamic Nucleus",
author = "Koch, {Christiane E} and Chrishanthi Lowe and Karen Legler and Jonas Benzler and Alisa Boucsein and Gregor B{\"o}ttiger and Grattan, {David R} and Williams, {Lynda M} and Alexander Tups",
note = "Date of Acecptance: 17/02/2014 Acknowledgments: This study was funded by the German Ministry of Education and Research (Grant 0315087 to A.T.). L.M.W. was funded by Rural and Environment Science and Analytical Services Division.",
year = "2014",
doi = "10.1210/en.2013-1734",
language = "English",
volume = "155",
pages = "1806--1816",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Central adiponectin acutely improves glucose tolerance in male mice

AU - Koch, Christiane E

AU - Lowe, Chrishanthi

AU - Legler, Karen

AU - Benzler, Jonas

AU - Boucsein, Alisa

AU - Böttiger, Gregor

AU - Grattan, David R

AU - Williams, Lynda M

AU - Tups, Alexander

N1 - Date of Acecptance: 17/02/2014 Acknowledgments: This study was funded by the German Ministry of Education and Research (Grant 0315087 to A.T.). L.M.W. was funded by Rural and Environment Science and Analytical Services Division.

PY - 2014

Y1 - 2014

N2 - Adiponectin, an adipocyte-derived hormone, regulates glucose and lipid metabolism. It is also antiinflammatory. During obesity, adiponectin levels and sensitivity are reduced. Whereas the action of adiponectin in the periphery is well established the neuroendocrine role of adiponectin is largely unknown. To address this we analyzed the expression of adiponectin and the 2 adiponectin receptors (AdipoR1 and AdipoR2) in response to fasting and to diet-induced and genetic obesity. We also investigated the acute impact of adiponectin on central regulation of glucose homeostasis. Adiponectin (1 μg) was injected intracerebroventricularly (ICV), and glucose tolerance tests were performed in dietary and genetic obese mice. Finally, the influence of ICV adiponectin administration on central signaling cascades regulating glucose homeostasis and on markers of hypothalamic inflammation was assessed. Gene expression of adiponectin was down-regulated whereas AdipoR1 was up-regulated in the arcuate nucleus of fasted mice. High-fat (HF) feeding increased AdipoR1 and AdipoR2 gene expression in this region. In mice on a HF diet and in leptin-deficient mice acute ICV adiponectin improved glucose tolerance 60 minutes after injection, whereas normoglycemia in control mice was unaffected. ICV adiponectin increased pAKT, decreased phospho-AMP-activated protein kinase, and did not change phospho-signal transducer and activator of transcription 3 immunoreactivity. In HF-fed mice, ICV adiponectin reversed parameters of hypothalamic inflammation and insulin resistance as determined by the number of phospho-glycogen synthase kinase 3 β(Ser9) and phospho-c-Jun N-terminal kinase (Thr183/Tyr185) immunoreactive cells in the arcuate nucleus and ventromedial hypothalamus. This study demonstrates that the insulin-sensitizing properties of adiponectin are at least partially based on a neuroendocrine mechanism that involves centrally synthesized adiponectin.

AB - Adiponectin, an adipocyte-derived hormone, regulates glucose and lipid metabolism. It is also antiinflammatory. During obesity, adiponectin levels and sensitivity are reduced. Whereas the action of adiponectin in the periphery is well established the neuroendocrine role of adiponectin is largely unknown. To address this we analyzed the expression of adiponectin and the 2 adiponectin receptors (AdipoR1 and AdipoR2) in response to fasting and to diet-induced and genetic obesity. We also investigated the acute impact of adiponectin on central regulation of glucose homeostasis. Adiponectin (1 μg) was injected intracerebroventricularly (ICV), and glucose tolerance tests were performed in dietary and genetic obese mice. Finally, the influence of ICV adiponectin administration on central signaling cascades regulating glucose homeostasis and on markers of hypothalamic inflammation was assessed. Gene expression of adiponectin was down-regulated whereas AdipoR1 was up-regulated in the arcuate nucleus of fasted mice. High-fat (HF) feeding increased AdipoR1 and AdipoR2 gene expression in this region. In mice on a HF diet and in leptin-deficient mice acute ICV adiponectin improved glucose tolerance 60 minutes after injection, whereas normoglycemia in control mice was unaffected. ICV adiponectin increased pAKT, decreased phospho-AMP-activated protein kinase, and did not change phospho-signal transducer and activator of transcription 3 immunoreactivity. In HF-fed mice, ICV adiponectin reversed parameters of hypothalamic inflammation and insulin resistance as determined by the number of phospho-glycogen synthase kinase 3 β(Ser9) and phospho-c-Jun N-terminal kinase (Thr183/Tyr185) immunoreactive cells in the arcuate nucleus and ventromedial hypothalamus. This study demonstrates that the insulin-sensitizing properties of adiponectin are at least partially based on a neuroendocrine mechanism that involves centrally synthesized adiponectin.

KW - Adiponectin

KW - Animals

KW - Anti-Inflammatory Agents, Non-Steroidal

KW - Arcuate Nucleus

KW - Diet, High-Fat

KW - Glucose Intolerance

KW - Hypoglycemic Agents

KW - Injections, Intraventricular

KW - Insulin Resistance

KW - Leptin

KW - Male

KW - Mice

KW - Mice, Inbred C57BL

KW - Mice, Obese

KW - Nerve Tissue Proteins

KW - Neurons

KW - Obesity

KW - Receptors, Adiponectin

KW - Signal Transduction

KW - Ventromedial Hypothalamic Nucleus

U2 - 10.1210/en.2013-1734

DO - 10.1210/en.2013-1734

M3 - Article

VL - 155

SP - 1806

EP - 1816

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -